Excess risk of major vascular diseases associated with airflow obstruction: a 9-year prospective study of 0.5 million Chinese adults

References

• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of COPDBethesda, MDGOLD2014
   Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• PeruzzaSSergiGVianelloAChronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of lifeRespir Med200397661261712814144
   PubMed Web of Science ®Google Scholar
• GroenewegenKHScholsAMWoutersEFMortality and mortality-related factors after hospitalization for acute exacerbation of COPDChest2003124245946712907529
   PubMed Web of Science ®Google Scholar
• TanWCBourbeauJHernandezPExacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based studyThorax201469870971724706040
   PubMed Web of Science ®Google Scholar
• CaugheyGEPreissAKVitryAIGilbertALRougheadEEComorbid diabetes and COPD: impact of corticosteroid use on diabetes complicationsDiabetes Care201336103009301423735725
   PubMed Web of Science ®Google Scholar
• ReganEJaramilloJIt’s the fracture that matters: bone disease in COPD patientsCOPD20129431932122876916
   PubMedGoogle Scholar
• LindbergALarssonLGRönmarkELündbackBCo-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung functionCOPD20118642142822149402
   PubMedGoogle Scholar
• LaurinCMoullecGBaconSLLavoieKLImpact of anxiety and depression on chronic obstructive pulmonary disease exacerbation riskAm J Respir Crit Care Med2012185991892322246177
   PubMed Web of Science ®Google Scholar
• FranssenFMRochesterCLComorbidities in patients with COPD and pulmonary rehabilitation: do they matter?Eur Respir Rev20142313113114124591670
   PubMedGoogle Scholar
• Van RemoortelHHornikxMLangerDRisk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20141891303824219412
   PubMed Web of Science ®Google Scholar
• BeranDZarHJPerrinCMenezesAMBurneyPBurden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countriesLancet Respir Med20153215917025680912
   PubMed Web of Science ®Google Scholar
• ChenZChenJCollinsRChina Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-upInt J Epidemiol20114061652166622158673
   PubMed Web of Science ®Google Scholar
• ChenZLeeLChenJCohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC)Int J Epidemiol20053461243124916131516
   PubMed Web of Science ®Google Scholar
• DuHBennettDLiLPhysical activity and sedentary leisure time and their associations with BMI, waist circumference, and percentage body fat in 0.5 million adults: the China Kadoorie Biobank studyAm J Clin Nutr201397348749623364014
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirom-etryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• QuanjerPHStanojevicSColeTJMulti-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equationsEur Respir J20124061324134322743675
   PubMed Web of Science ®Google Scholar
• PlummerMImproved estimates of floating absolute riskStat Med20042319310414695642
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
   PubMed Web of Science ®Google Scholar
• McAllisterDAMaclayJDMillsNLDiagnosis of myocardial infarction following hospitalisation for exacerbation of COPDEur Respir J20123951097110322323574
   PubMed Web of Science ®Google Scholar
• GershonASMecredyGCGuanJVictorJCGoldsteinRToTQuantifying comorbidity in individuals with COPD: a population studyEur Respir J2015451515925142481
   PubMed Web of Science ®Google Scholar
• ToTStanojevicSMooresGGlobal asthma prevalence in adults: findings from the cross-sectional world health surveyBMC Public Health20121220422429515
   PubMed Web of Science ®Google Scholar
• ZhangWChenXMaLEpidemiology of bronchial asthma and asthma control assessment in Henan Province, ChinaTransl Respir Med20142525505697
   PubMedGoogle Scholar
• KurmiOPLiLSmithMRegional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB)BMJ Open Respir Res201411e000025
   PubMedGoogle Scholar
• DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
   PubMed Web of Science ®Google Scholar
• VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
   PubMed Web of Science ®Google Scholar
• FearyJRRodriguesLCSmithCJHubbardRBGibsonJEPrevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary careThorax2010651195696220871122
   PubMed Web of Science ®Google Scholar
• AryalSDiaz-GuzmanEManninoDPrevalence of COPD and comorbidityEur Respir Monogr201359112
   Google Scholar
• SchneiderCBothnerUJickSMeierCChronic obstructive pulmonary disease and the risk of cardiovascular diseasesEur J Epidemiol201025425326020191376
   PubMed Web of Science ®Google Scholar
• SidneySSorelMQuesenberryCPJrDeLuiseCLanesSEisnerMDCOPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care ProgramChest200512842068207516236856
   PubMed Web of Science ®Google Scholar
• VanfleterenLESpruitMAGroenenMTArterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitationEur Respir J20144351306131524311762
   PubMed Web of Science ®Google Scholar
• SodeBFDahlMNordestgaardBGMyocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individualsEur Heart J201132192365237521875856
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• SzollosiIThompsonBRKrumHKayeDMNaughtonMTImpaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severityChest20081341677218198261
   PubMed Web of Science ®Google Scholar
• Intercollegiate Stroke Working PartyNational Clinical Guideline for StrokeLondonRoyal College of Physicians2016
   Google Scholar
• YanbaevaDGDentenerMACreutzbergECWesselingGWoutersEFSystemic effects of smokingChest200713151557156617494805
   PubMed Web of Science ®Google Scholar
• HoffmannBMoebusSDraganoNChronic residential exposure to particulate matter air pollution and systemic inflammatory markersEnviron Health Perspect200911781302130819672412
   PubMed Web of Science ®Google Scholar
• LokeYKCavallazziRSinghSRisk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studiesThorax201166869970821602540
   PubMed Web of Science ®Google Scholar